Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Arthritis, Psoriatic; Psoriasis; Spond...

Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing, Date of authorisation: 14/01/2015, Revision: 30, Status: Authorised
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing, Date of authorisation: 14/01/2015, Revision: 30, Status: Authorised
 
Wil je het laatste nieuws in jouw mailbox ontvangen?
Meld je dan aan voor de nieuwsbrief.